LPL Financial
BEAM icon

LPL Financial’s Beam Therapeutics BEAM Stock Holding History

LPL Financial’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.94M Sell
56,646
-10,287
-15% -$311K ﹤0.01% 3771
2026
Q1 		$1.6M Buy
66,933
+11,314
+20% +$314K ﹤0.01% 3713
2025
Q4 		$1.54M Buy
55,619
+11,872
+27% +$303K ﹤0.01% 3635
2025
Q3 		$1.06M Buy
43,747
+7,514
+21% +$149K ﹤0.01% 3943
2025
Q2 		$616K Buy
36,233
+6,776
+23% +$118K ﹤0.01% 4201
2025
Q1 		$575K Buy
29,457
+1,759
+6% +$46.1K ﹤0.01% 4037
2024
Q4 		$687K Buy
27,698
+1,462
+6% +$37.3K ﹤0.01% 3814
2024
Q3 		$643K Sell
26,236
-196
-0.7% -$5.06K ﹤0.01% 3785
2024
Q2 		$619K Buy
26,432
+2,536
+11% +$62.3K ﹤0.01% 3678
2024
Q1 		$790K Buy
23,896
+2,132
+10% +$66.4K ﹤0.01% 3400
2023
Q4 		$592K Buy
21,764
+5,576
+34% +$139K ﹤0.01% 3531
2023
Q3 		$389K Sell
16,188
-11,831
-42% -$317K ﹤0.01% 3687
2023
Q2 		$895K Buy
28,019
+4,535
+19% +$147K ﹤0.01% 2929
2023
Q1 		$719K Buy
23,484
+5,677
+32% +$224K ﹤0.01% 3029
2022
Q4 		$696K Buy
17,807
+2,907
+20% +$130K ﹤0.01% 2956
2022
Q3 		$710K Sell
14,900
-6,513
-30% -$372K ﹤0.01% 2817
2022
Q2 		$829K Buy
21,413
+3,120
+17% +$124K ﹤0.01% 2739
2022
Q1 		$1.05M Buy
18,293
+3,868
+27% +$254K ﹤0.01% 2575
2021
Q4 		$1.15M Sell
14,425
-2,528
-15% -$216K ﹤0.01% 2543
2021
Q3 		$1.48M Buy
16,953
+31
+0.2% +$3.11K ﹤0.01% 2282
2021
Q2 		$2.18M Buy
16,922
+10,970
+184% +$874K ﹤0.01% 1907
2021
Q1 		$476K Buy
5,952
+2,221
+60% +$211K ﹤0.01% 3062
2020
Q4 		$305K Buy
+3,731
New +$183K ﹤0.01% 3184

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

LPL Financial's BEAM Position: Q2 2026 in Review

LPL Financial reduced its Beam Therapeutics (BEAM) stake by 15% in Q2 2026, selling an estimated $311K and leaving 56,646 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #3771.

LPL Financial first reported a position in BEAM in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.18M in Q2 2021. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • LPL Financial held 56,646 shares of Beam Therapeutics worth $1.94M as of Q2 2026.
  • LPL Financial sold 10,287 Beam Therapeutics shares in Q2 2026, an estimated $311K.
  • Beam Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #3771 holding.
  • LPL Financial first reported a position in Beam Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • LPL Financial's Beam Therapeutics position peaked at $2.18M in Q2 2021.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.